A multi-centre, prospective, non-interventional, single-arm study investigating glycaemic control associated with the use of Dose Check app and insulin degludec in patients with type 2 diabetes mellitus in Saudi Arabia under real-world setting
Device
A multi-centre, prospective, non-interventional, single-arm study investigating glycaemic control associated with the use of Dose Check app and insulin degludec in patients with type 2 diabetes mellitus in Saudi Arabia under real-world setting
Protocol number
NN1250-7588 V 2.0
License Number
Novo Nordisk A/V
Status
Completed
Trial site
Dr. Sulaiman Al-Habib Hospital AL Qassim, Buraydah
